Publication

Anandamide modulation of endotoxin-induced inflammation

Kerr, Daniel M.
; 
Henry, Rebecca
; 
Roche, Michelle
Thumbnail Image
Files
Thumbnail Image
Kerr_et_al_2013_Anat_and_Phys-_anandamide-modulation-of-endotoxin_induced_inflammation.pdf
Adobe PDF, 380.83 KB
Identifiers
http://hdl.handle.net/10379/5749
 https://doi.org/10.13025/22569
Publication Date
2013-12-20
Keywords
Type
Article
Downloads
Show all metadata
Citation
Kerr DM, Henry R, Roche M (2013) 'Anandamide Modulation of Endotoxin-Induced Inflammation' Anatomy and Physiology, 4:e130. doi: 10.4172/2161-0940.1000e130
Abstract
The endocannabinoid system is comprised of the CB1 and CB2 receptors, the naturally occurring endogenous ligands, anandamide (AEA) and 2-arachidonyl glycerol (2-AG); and the enzymes involved in their synthesis and degradation. The enzyme fatty acid amide hydrolyase (FAAH) preferentially metabolises AEA, and the related N-acylethanolamines, N-palmitoylethanolamide (PEA) and N-oleoylethanolamide (OEA). While PEA and OEA do not have activity at CB1/2 receptors, they are capable of enhancing AEA signaling by competing with AEA at the catalytic site on the FAAH enzyme. All elements of the endocannabinoid system are widely and densely expressed in the mammalian immune system and brain and as such represent an important therapeutic target for a number of peripheral and central inflammatory disorders [1-3].
Funder
|~|
Publisher
OMICS International
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland
cbn
Collections
Physiology (Scholarly Articles)